Currently, two vaccines - Covishield and covaxin - are being used in the ongoing vaccination campaign against Corona in India. A third vaccine may be added soon. This Russian vaccine is expected to be Sputnik V. Dr Reddy's Laboratory, a Hyderabad-based company in India, is conducting its trials and is expected to approach the drug regulator in March for emergency approval. This vaccine will be available in India for $ 10 (about Rs 730).
Of the 10 vaccines approved worldwide, Sputnik V as well as the vaccines of American companies Pfizer and Mordana have proved to be more than 90% effective. For this reason, the fight against Corona can be expected to be strengthened with the availability of the Russian vaccine in India. The Russian vaccine has been created by the Gamalaya Institute of Russia and funded by the Russian Direct Investment Fund (RDIF). RDIF is also doing the deal on this vaccine from around the world.
RDIF CEO Kirill Dmitriev said that the price of the Moderna and Pfizer vaccines, which currently prove more than 90% efficacy, is three times the price of Sputnik V. With this, the Russian vaccine is being tried to reach more and more countries all over the world. The good thing is that it can be stored at a temperature of 2 to 8 ° C which is readily available in the current supply chain. The Russian vaccine is composed of two adenovirus vectors. The company is currently in talks with British firm AstraZeneca on combined trials with its vaccine - CoveShield. The company claims that the effectiveness of the AstraZeneca vaccine will increase further.
India will have the most effective and affordable vaccine
If the Russian vaccine is successful in all trials and is approved in India, it will be the most effective vaccine in trials. The efficacy of the Covishield vaccine being used in India has been 70%, while the phase-3 trials of Covaxin have not been completed yet. Because of this, the situation regarding its effectiveness is not clear.
The government is getting one dose of Covshield for 200 rupees and one dose of Covaxin for 295 rupees. At the same time, CoviShield's dose in the market will be Rs 1,000. Covaxin has not yet disclosed the market price. In such a situation, Sputnik V priced at Rs 730 can be the cheapest and effective vaccine in the market.
Which countries have received approval so far
Dimitrev said Sputnik V has so far received approval in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. Hungary has become the first country in the European Union to approve it. Approval can be obtained soon from the Drug Regulator of the European Union.
In the 5 seasons of the upcoming series The Lord of the Rings- Rings of Power, more than 1 billio
In the IPL match played between Rajasthan and Bangalore on Tuesday, a high voltage drama was seen
Twitter on Wednesday added the 'official' label to the handles of leaders including Prime Ministe
Coronavirus Updates: Corona's speed increased again, with 5443 new cases in 24 hours; 26 people died
Corona cases have increased in the country. The Health Ministry said that a total of 5,443 new ca
I2U2 Summit: The first meeting of the leaders of the I2U2 group countries took place today. India
Independence Day 2023: On August 15, 1947, after a long struggle and the sacrifice of many freedo
People are risking their lives to leave the country after the Taliban took over Afghanistan. On M
'Show some mercy,' Vijay Verma lashes out at media over Malaika Arora's father's suicide case.
After the death of father Anil Mehta, the family of actress Malaika Arora and Amrita Arora is goi
Anushka Sharma: 'God is the best scriptwriter', Anushka Sharma wrote a post praising Virat
The Indian cricket team has secured its place in the final by registering victory in the World Cu
Britain's first space mission 'The Start Me Up' failed late on Monday night. Virgin Orbit, the co
